We found that general obesity was associated with all-cause mortality and BCSM in ER/PR+ HER2–, and HER2+ breast cancer patients, while no clear associations were observed in TNBC patients. Here, ERBB2 is linked to obesity due to melanocortin 4 receptor deficiency.